Cargando…

Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study

OBJECTIVE: To ascertain the use of secondary prevention medications and cardiac rehabilitation after an acute coronary syndrome (ACS) and the impact on 2-year outcomes. METHODS: CONCORDANCE (Cooperative National Registry of Acute Coronary care, Guideline Adherence and Clinical Events) is a prospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chow, Clara K, Brieger, David, Ryan, Mark, Kangaharan, Nadarajah, Hyun, Karice K, Briffa, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340555/ https://www.ncbi.nlm.nih.gov/pubmed/30728864 http://dx.doi.org/10.1136/heartasia-2018-011122

Ejemplares similares

Outcomes of anemic patients presenting with acute coronary syndrome: An analysis of the Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events
por: Huynh, Ronald, et al.
Publicado: (2019)

The household economic burden for acute coronary syndrome survivors in Australia
por: Hyun, Karice K., et al.
Publicado: (2016)

Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand
por: Redfern, Julie, et al.
Publicado: (2014)

The effect of socioeconomic disadvantage on prescription of guideline-recommended medications for patients with acute coronary syndrome: systematic review and meta-analysis
por: Hyun, Karice K., et al.
Publicado: (2017)

TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol
por: Chow, Clara K, et al.
Publicado: (2018)

Impact of the “Warning Signs Campaign” on Characteristics of Patients Presenting with Acute Coronary Syndrome (ACS) to Hospitals
por: Redwood, Eleanor, et al.
Publicado: (2022)

Modular prevention of heart disease following acute coronary syndrome (ACS) [ISRCTN42984084]
por: Redfern, Julie, et al.
Publicado: (2006)

Objective risk assessment vs standard care for acute coronary syndromes—The Australian GRACE Risk tool Implementation Study (AGRIS): a process evaluation
por: Gullick, Janice, et al.
Publicado: (2022)

Data-driven quality improvement program to prevent hospitalisation and improve care of people living with coronary heart disease: Protocol for a process evaluation
por: Hafiz, Nashid, et al.
Publicado: (2022)

QUality improvement in primary care to prevent hospitalisations and improve Effectiveness and efficiency of care for people Living with coronary heart disease (QUEL): protocol for a 24-month cluster randomised controlled trial in primary care
por: Redfern, Julie, et al.
Publicado: (2020)

ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes?
por: Vernon, Stephen T., et al.
Publicado: (2019)

New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome
por: Goto, Shinya, et al.
Publicado: (2014)

Pulmonary hypertension in remote and disadvantaged population: overcoming unique challenges for improved outcomes
por: Naing, Pyi, et al.
Publicado: (2022)

Present and future of secondary prevention after an acute coronary syndrome
por: Keller, Pierre-Frederic, et al.
Publicado: (2011)

Use of medicines recommended for secondary prevention of acute coronary syndrome
por: Gaedke, Mari Ângela, et al.
Publicado: (2015)

Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome
por: Berger, Jeffrey S.
Publicado: (2018)

Prognostic benefit of catheter ablation of atrial fibrillation in heart failure: An updated meta‐analysis of randomized controlled trials
por: Virk, Sohaib A., et al.
Publicado: (2023)

The effects of a lifestyle-focused text-messaging intervention on adherence to dietary guideline recommendations in patients with coronary heart disease: an analysis of the TEXT ME study
por: Santo, Karla, et al.
Publicado: (2018)

Effect of an avatar-based discharge education application on knowledge and behaviour in people after acute coronary syndrome: protocol for a pragmatic prospective randomised controlled trial
por: Ellis, Tiffany, et al.
Publicado: (2023)

Prosthetic valve endocarditis presenting as meningoencephalitis complicated by pseudo-aneurysms in a remote Aboriginal healthcare setting in Australia: a case report
por: Watson, Anna Louise, et al.
Publicado: (2021)

Falling hospital and postdischarge mortality following CABG in New South Wales from 2000 to 2013
por: Brieger, David B, et al.
Publicado: (2019)

Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden
por: Begum, Najida, et al.
Publicado: (2015)

Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq
por: Nassr, Ola A., et al.
Publicado: (2019)

Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary Syndrome
por: Fitchett, David H., et al.
Publicado: (2020)

Outcomes after first percutaneous coronary intervention for acute myocardial infarction according to patient funding source
por: Bradshaw, Pamela J, et al.
Publicado: (2014)

Betaine and Secondary Events in an Acute Coronary Syndrome Cohort
por: Lever, Michael, et al.
Publicado: (2012)

Changing the Landscape of Secondary Prevention After Acute Coronary Syndrome: Morphology, Physiology, or Both?
por: Otake, Hiromasa
Publicado: (2022)

Predicting Statin Adherence Following Hospital Discharge for Acute Coronary Syndromes: What’s the Score?
por: Barlow, Thomas R., et al.
Publicado: (2023)

Acute Coronary Syndrome Secondary to Aortocaval Fistula
por: Cruz-Utrilla, Alejandro, et al.
Publicado: (2019)

Are there gender differences in acute management and secondary prevention of acute coronary syndromes in Barbados? A cohort study
por: Sobers, Natasha, et al.
Publicado: (2019)

The effect of a game-based mobile app ‘MyHeartMate’ to promote lifestyle change in coronary disease patients: a randomized controlled trial
por: Gallagher, Robyn, et al.
Publicado: (2022)

Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
por: Husted, Steen
Publicado: (2015)

Use of Secondary Prevention Drug Therapy in Patients With Acute Coronary Syndrome After Hospital Discharge
por: Lee, Helen Y., et al.
Publicado: (2008)

Pericoronary adipose tissue attenuation on coronary computed tomography angiography associates with male sex and Indigenous Australian status
por: Yuvaraj, Jeremy, et al.
Publicado: (2023)

Smartphone-guided secondary prevention for patients with coronary artery disease
por: Eckardt, Irina, et al.
Publicado: (2021)

Age-Related Variation in the Provision of Primary Care Services and Medication Prescriptions for Patients with Cardiovascular Disease
por: Tu, Qiang, et al.
Publicado: (2022)

Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets
por: Silverio, Angelo, et al.
Publicado: (2023)

Suboptimal Utilization of Secondary Drug Prevention in Acute Coronary Syndrome: Measurement Issues and Managed Care Opportunities
por: Quilliam, Brian J.
Publicado: (2008)

Long-term use of secondary prevention medications for heart failure in Western Australia: a protocol for a population-based cohort study
por: Qin, Xiwen, et al.
Publicado: (2016)

Impact of briefly-assessed depression on secondary prevention outcomes after acute coronary syndrome: a one-year longitudinal survey
por: McGee, Hannah M, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_phi2f4umt64a1nneo3tmu35dgi